Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future PerspectivesDavide Fiore Bavaro, Annalisa Saracino, Salvatore Grasso et al.|Antibiotics|2021Cited by 95
Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort StudyDavide Fiore Bavaro, Annalisa Saracino, Roberta Papagni et al.|Infectious Diseases and Therapy|2023Cited by 29
Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective StudyDavide Fiore Bavaro, Annalisa Saracino, Lucia Diella et al.|Viruses|2023Cited by 13
Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort studyDavide Fiore Bavaro, Annalisa Saracino, Alessandra Belati et al.|Journal of Antimicrobial Chemotherapy|2023Cited by 13
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infectionDF Bavaro, Annalisa Saracino, Lucia Diella et al.|Pathogens and Global Health|2022Cited by 10